Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Gastroenterology
|
May 4, 2016
Biliary Cirrhosis Treated With Ursodeoxycholic Acid
Robert H Palmer
Annals of Internal Medicine
|
January 5, 2002
Osteoarthritis: new insights
Robert H Palmer
The Annals of Pharmacotherapy
|
August 5, 2011
Correction: milnacipran for treatment of fibromyalgia
Robert H Palmer
JAMA
|
December 18, 2003
Results of clinical trials sponsored by for-profit vs nonprofit entities
Robert H Palmer
JAMA
|
May 22, 2002
When are medication side effects due to the nocebo phenomenon?
Robert H Palmer
BMJ (Clinical Research Ed.)
|
January 10, 2003
Alosetron for irritable bowel syndrome. Risks of using alosetron are still unknown
Robert H Palmer
JAMA
|
June 26, 2003
Adverse drug effects in ambulatory elderly patients
Robert H Palmer
Pain
|
June 5, 2012
Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses
Robert H Palmer
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 25, 2018
Predictors of the Placebo Response in Irritable Bowel Syndrome With Constipation
Robert H Palmer
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 2, 2015
Risk of Upper and Lower Gastrointestinal Bleeding in Patients Taking Nonsteroidal Anti-Inflammatory Drugs, Antiplatelet Agents, or Anticoagulants
Robert H Palmer
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Gastroenterology
|
May 4, 2016
Biliary Cirrhosis Treated With Ursodeoxycholic Acid
Robert H Palmer
Annals of Internal Medicine
|
January 5, 2002
Osteoarthritis: new insights
Robert H Palmer
The Annals of Pharmacotherapy
|
August 5, 2011
Correction: milnacipran for treatment of fibromyalgia
Robert H Palmer
JAMA
|
December 18, 2003
Results of clinical trials sponsored by for-profit vs nonprofit entities
Robert H Palmer
JAMA
|
May 22, 2002
When are medication side effects due to the nocebo phenomenon?
Robert H Palmer
BMJ (Clinical Research Ed.)
|
January 10, 2003
Alosetron for irritable bowel syndrome. Risks of using alosetron are still unknown
Robert H Palmer
JAMA
|
June 26, 2003
Adverse drug effects in ambulatory elderly patients
Robert H Palmer
Pain
|
June 5, 2012
Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses
Robert H Palmer
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 25, 2018
Predictors of the Placebo Response in Irritable Bowel Syndrome With Constipation
Robert H Palmer
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 2, 2015
Risk of Upper and Lower Gastrointestinal Bleeding in Patients Taking Nonsteroidal Anti-Inflammatory Drugs, Antiplatelet Agents, or Anticoagulants
Robert H Palmer
Page
of 4